| Market cap | $1.67B |
|---|---|
| Enterprise value | $570.09M |
| Revenue | $1.138B |
|---|---|
| EBITDA | $37.200M |
| Income | -$57.90 |
| Revenue Q/Q | -7.35% |
| Revenue Y/Y | -2.46% |
| P/E | N/A |
|---|---|
| Forward P/E | 3.93 |
| EV/Sales | 0.50 |
| EV/EBITDA | 15.33 |
| EV/EBIT | N/A |
| PEG | 0.55 |
| Price/Sales | 1.47 |
| P/FCF | 86.73 |
| Price/Book | 1.78 |
| Book/Share | 5.53 |
| Cash/Share | 0.92 |
| FCF yield | 1.15% |
| Volume | 397.255k / 346.450k |
|---|---|
| Relative vol. | 1.15 × |
| EPS | N/A |
|---|---|
| EPS Q/Q | -23.68% |
| Est. EPS Q/Q | -11.11% |
| Profit margin | 6.54% |
|---|---|
| Oper. margin | -3.69% |
| Gross margin | 22.39% |
| EBIT margin | -3.83% |
| EBITDA margin | 3.27% |
| Ret. on assets | -3.78% |
|---|---|
| Ret. on equity | -6.52% |
| ROIC | 6.28% |
| ROCE | -3.46% |
| Debt/Equity | 0.66 |
|---|---|
| Net debt/EBITDA | 23.40 |
| Current ratio | 2.74 |
| Quick ratio | 1.85 |
| Volatility | 5.25% |
|---|---|
| Beta | 1.12 |
| RSI | 42.59 |
|---|
| Insider ownership | N/A |
|---|---|
| Inst. ownership | N/A |
| Shares outst. | 35.391M |
|---|---|
| Shares float | 0.000 0.00% |
| Short % of float | 2.38% |
| Short ratio | 4.18 |
| Dividend | $0.56 |
|---|---|
| Dividend yield | 5.85% |
| Payout ratio | 35.44% |
| Payment date | 26 Jul 2024 |
| Ex-dividend date | 12 Jul 2024 |
| Earnings date | 11 Jul 2024 |
Tuesday, 21 June 2022
|
|
| Methode Electronics Has Re-Affirmed Its Dividend Of US$0.14 | |
Monday, 28 March 2022
|
|
| Investing in Methode Electronics three years ago would have delivered you a 53% gain | |
Wednesday, 8 December 2021
|
|
| Methode Electronics Inc COO Joseph Elias Khoury Sold $909,000 of Shares | |
Thursday, 24 June 2021
|
|
| Methode Electronics, Inc. Reports Fiscal 2021 Fourth Quarter and Full Year Financial Results - Yahoo Finance | |
Wednesday, 2 June 2021
|
|
| Methode Electronics to Present at the Stifel 2021 Virtual Cross Sector Insight Conference - Yahoo Finance | |
Thursday, 4 March 2021
|
|
| Methode Electronics, Inc. to Host Earnings Call - Yahoo Finance | |
Monday, 28 September 2020
|
|
| Alligator Bioscience appoints Gayle Mills as Chief Business Officer | |
Wednesday, 16 September 2020
|
|
| Alligator Bioscience receives patent approval for the drug candidate ATOR-1015 | |
Wednesday, 9 September 2020
|
|
| Alligator Bioscience presents an update regarding the Phase I study with the drug candidate ATOR-1015 | |
Friday, 4 September 2020
|
|
| Alligator Bioscience presents positive biomarker data demonstrating proof of mechanism in mitazalimab clinical Phase I study | |
Thursday, 27 August 2020
|
|
| Alligator Bioscience: Encouraging interim safety data in ATOR-1017 clinical Phase I study | |
Tuesday, 25 August 2020
|
|
| Alligator Bioscience Virtual R&D Day - August 27, 2020 | |
| Alligator Bioscience presents the clinical project portfolio at Virtual R&D Day August 27, 2020 | |
Monday, 13 July 2020
|
|
| Alligator Bioscience AB Interim Report January-June 2020 | |
Tuesday, 30 June 2020
|
|
| Were Hedge Funds Right About Selling Methode Electronics Inc. ? | |
| Methode Q4 Earnings and Revenues Miss Estimates | |
Monday, 22 June 2020
|
|
| Cohen & Steers MLP Income and Energy Opportunity Fund Announces Share Repurchases | |
Monday, 15 June 2020
|
|
| Alligator Bioscience Appoints New CFO | |
Thursday, 4 June 2020
|
|
| Alligator Bioscience and Scandion Oncology Sign Preclinical Agreement to Explore Combination Therapies for Chemotherapy and Immuno-oncology | |
Monday, 1 June 2020
|
|
| Alligator Bioscience's Collaboration With Biotheus Inc. Proceeds and Second Payment is Received | |
Friday, 29 May 2020
|
|
| Alligator Bioscience Presents Novel Supportive Phase I Data at ASCO for its CTLA-4 x OX40 Bispecific Drug Candidate ATOR-1015 | |
Monday, 25 May 2020
|
|
| Volatility 101: Should Methode Electronics Shares Have Dropped 37%? | |
Sunday, 12 April 2020
|
|
| Why You Might Be Interested In Methode Electronics, Inc. For Its Upcoming Dividend | |
Friday, 10 April 2020
|
|
| Should Value Investors Buy Methode Stock? | |
| Insider |
Trans.
Transaction
|
Total value |
|---|---|---|
| Donald W Duda Chief Executive Officer | Buy 21 Sep 2023 | $506,741 |
| Walter J Aspatore | Buy 20 Sep 2023 | $22,500 |
| Donald W Duda Chief Executive Officer | Option 12 Dec 2022 | $268,174 |
| Lawrence B Skatoff Director | Sale 9 Dec 2022 | $93,800 |
| Brian J Cadwallader | Sale 8 Dec 2022 | $102,960 |
| Donald W Duda Chief Executive Officer | Option 7 Dec 2022 | $1,212,226 |
| Walter J Aspatore | Sale 6 Dec 2022 | $438,030 |
| Darren Dawson | Sale 6 Dec 2022 | $168,490 |
| Joseph Elias Khoury Chief Operating Officer | Sale 19 Sep 2022 | $462,000 |
| Joseph Elias Khoury Chief Operating Officer | Sale 28 Jun 2022 | $308,400 |
| Lawrence B Skatoff Director | Sale 17 Dec 2021 | $35,912 |
Powered by
Robintrack.
Price target
Current $10.03
Average $36.00
Low $34
High $38
Dividends
| Ex-dividend date | 12 Jul 2024 | Frequency | Quarterly | Annual dividend | +0.00% |
|---|---|---|---|---|---|
| Next dividend | 26 Jul 2024 | Dividend yield | 5.85% | Growth period | 3 years |
| Last dividend date | Yield 3 years | 3.19% | Growth 3 years | +8.37% | |
| Last dividend | Yield 5 years | 2.35% | Growth 5 years | +4.94% |
| Insider | Age | Since | Compensation |
|---|---|---|---|
| Donald W. Duda (66) Pres, CEO, and Director | 66 | $2,726,554 | |
| Donald Duda (64) President, Chief Executive Officer, and Director since 2004 | 64 | 2004 | $1,515,120 |
| Andrea Barry (57) Chief Human Resource Officer since 2017 | 57 | 2017 | $1,410,510 |
| Joseph E. Khoury (57) Chief Operating Officer | 57 | $1,270,734 | |
| Ronald L.G. Tsoumas (60) VP of Corp. Fin. and CFO | 60 | $1,002,894 | |
| Kevin Michael Martin | $837,353 | ||
| Joseph Khoury (56) Chief Operating Officer and Senior Vice President since 2018 | 56 | 2018 | $711,754 |
| Andrea Jean Barry (58) Exec. VP and Chief HR Officer | 58 | $708,378 | |
| Anil Shetty (54) Vice President, General Manager - Asia, and President - Dabir since 2018 | 54 | 2018 | $652,194 |
| Ronald Tsoumas (59) Chief Financial Officer since 2018 | 59 | 2018 | $630,058 |
| Timothy Glandon (56) Vice President since 2015 | 56 | 2015 | $326,455 |
| Walter Aspatore (77) Independent Chairman of the Board since 2012 | 77 | 2012 | $194,780 |
| Darren Dawson (57) Independent Director since 2004 | 57 | 2004 | $175,530 |
| Lawrence Skatoff (80) Independent Director since 2004 | 80 | 2004 | $159,280 |
| Brian Cadwallader (61) Independent Director since 2018 | 61 | 2018 | $159,280 |
| Bruce Crowther (68) Independent Director since 2019 | 68 | 2019 | $142,030 |
| Mark Schwabero (67) Independent Director since 2019 | 67 | 2019 | $129,280 |
| David Blom (66) Independent Director since 2019 | 66 | 2019 | $20,500 |
| Angelo Pantaleo (60) Independent Director since 2019 | 60 | 2019 | $18,500 |
| Mary Lindsey (64) Independent Director since 2020 | 64 | 2020 | $11,000 |
| Therese Bobek (59) Independent Director since 2020 | 59 | 2020 | $11,000 |
| Robert Cherry | 2020 | ||
| Anil V. Shetty (55) VP, Pres of Dabir Surfaces, and Inc. | 55 | ||
| Mark Shermetaro | |||
| Kristine Walczak | |||
| Amit N. Patel |
methode electronics, inc. (nyse: mei) is an international engineering company headquartered in chicago, il. methode was founded in 1946 as a single-product manufacturer and has since expanded its business into industrial design, distribution and professional services. here at methode, we utilize technical capabilities to develop custom-engineered application-specific products and solutions for a variety of markets and customers. this includes the industries of automotive, big data, white goods, aerospace & defense, consumer electronics and healthcare. for additional information, visit methode.com.
- Technology > Electronic Components
- Methode Electronics, Inc., 8750 West Bryn Mawr Avenue, Chicago 60631-3518, United States
- 708 867 6777
- Investor relations
Dividends
| Ex-dividend date | 12 Jul 2024 | Frequency | Quarterly | Annual dividend | +0.00% |
|---|---|---|---|---|---|
| Next dividend | 26 Jul 2024 | Dividend yield | 5.85% | Growth period | 3 years |
| Last dividend date | Yield 3 years | 3.19% | Growth 3 years | +8.37% | |
| Last dividend | Yield 5 years | 2.35% | Growth 5 years | +4.94% |
Quarterly EPS estimates
Profit margin
Debt to assets
Cash flow
Balance sheet
XSLX
| (in millions USD) | 31 Dec 2023 | 30 Sep 2023 | |||
|---|---|---|---|---|---|
| Current assets | |||||
| Cash | $122.9 | $122.5 | |||
| Short term investments | |||||
| Net receivables | $265.3 | $292.3 | |||
| Inventory | $204 | $183.9 | |||
| Total current assets | $629.8 | $636.5 | |||
| Long term investments | |||||
| Property, plant & equipment | $258.4 | $251.5 | |||
| Goodwill & intangible assets | $484.7 | $485.4 | |||
| Total noncurrent assets | $861.7 | $848.4 | |||
| Total investments | |||||
| Total assets | $1,491.5 | $1,484.9 | |||
| Current liabilities | |||||
| Accounts payable | $146 | $133.5 | |||
| Deferred revenue | |||||
| Short long term debt | $6.5 | $9.6 | |||
| Total current liabilities | $229.9 | $218.3 | |||
| Long term debt | $351 | $349.9 | |||
| Total noncurrent liabilities | $426.6 | $421.7 | |||
| Total debt | $357.5 | $359.5 | |||
| Total liabilities | $656.5 | $640 | |||
| Stockholders' equity | |||||
| Retained earnings | $677.6 | $697 | |||
| Other stockholder equity | -$31.2 | -$42.9 | |||
| Total stockholder equity | $835 | $844.9 | |||
| (in millions USD) | 2023 | 2022 | ||
|---|---|---|---|---|
| Current assets | ||||
| Cash | $157 | $172 | ||
| Short term investments | ||||
| Net receivables | $314.3 | $273.3 | ||
| Inventory | $159.7 | $158.5 | ||
| Total current assets | $664.4 | $629 | ||
| Long term investments | ||||
| Property, plant & equipment | $248.7 | $217 | ||
| Goodwill & intangible assets | $558.6 | $440.7 | ||
| Total noncurrent assets | $914.7 | $760.1 | ||
| Total investments | ||||
| Total assets | $1,579.1 | $1,389.1 | ||
| Current liabilities | ||||
| Accounts payable | $138.7 | $108.5 | ||
| Deferred revenue | ||||
| Short long term debt | $10 | $19 | ||
| Total current liabilities | $228 | $188.6 | ||
| Long term debt | $325.4 | $212.3 | ||
| Total noncurrent liabilities | $398.2 | $286.7 | ||
| Total debt | $335.4 | $231.3 | ||
| Total liabilities | $626.2 | $475.3 | ||
| Stockholders' equity | ||||
| Retained earnings | $772.7 | $763.9 | ||
| Other stockholder equity | -$19 | -$26.8 | ||
| Total stockholder equity | $941.8 | $913.8 | ||
Income statement
| (in millions USD) | 31 Dec 2023 | 30 Sep 2023 | |||
|---|---|---|---|---|---|
| Revenue | |||||
| Total revenue | $259.5 | $288 | |||
| Cost of revenue | $222.5 | $235.7 | |||
| Gross profit | $37 | $52.3 | |||
| Operating activities | |||||
| Research & development | |||||
| Selling, general & administrative | $33.9 | $40.9 | |||
| Total operating expenses | $40 | $103.6 | |||
| Operating income | -$3 | -$51.3 | |||
| Income from continuing operations | |||||
| EBIT | -$5.5 | -$51.1 | |||
| Income tax expense | $1.1 | -$0.2 | |||
| Interest expense | $5 | $4.4 | |||
| Net income | |||||
| Net income | -$11.6 | -$55.3 | |||
| Income (for common shares) | -$11.6 | -$55.3 | |||
| (in millions USD) | 2023 | 2022 | ||
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1,179.6 | $1,163.6 | ||
| Cost of revenue | $915.5 | $898.7 | ||
| Gross profit | $264.1 | $264.9 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $154.9 | $134.1 | ||
| Total operating expenses | $173.7 | $153.2 | ||
| Operating income | $90.4 | $111.7 | ||
| Income from continuing operations | ||||
| EBIT | $92.8 | $122 | ||
| Income tax expense | $13 | $16.3 | ||
| Interest expense | $2.7 | $3.5 | ||
| Net income | ||||
| Net income | $77.1 | $102.2 | ||
| Income (for common shares) | $77.1 | $102.2 | ||
Cash flows
| (in millions USD) | 31 Dec 2023 | 30 Sep 2023 | |||
|---|---|---|---|---|---|
| Net income | -$11.6 | -$55.3 | |||
| Operating activities | |||||
| Depreciation | $14.9 | $14.4 | |||
| Business acquisitions & disposals | |||||
| Stock-based compensation | -$2.1 | $1.3 | |||
| Total cash flows from operations | $28.8 | -$0.6 | |||
| Investing activities | |||||
| Capital expenditures | -$16.6 | -$10.7 | |||
| Investments | $0.6 | ||||
| Total cash flows from investing | -$16.7 | -$8.5 | |||
| Financing activities | |||||
| Dividends paid | -$4.9 | -$4.8 | |||
| Sale and purchase of stock | -$3 | -$7.8 | |||
| Net borrowings | -$9 | $2.7 | |||
| Total cash flows from financing | -$16.9 | -$10.6 | |||
| Effect of exchange rate | $5.2 | -$5.7 | |||
| Change in cash and equivalents | $0.4 | -$25.4 | |||
| (in millions USD) | 2023 | 2022 | ||
|---|---|---|---|---|
| Net income | $77.1 | $102.2 | ||
| Operating activities | ||||
| Depreciation | $49.5 | $52.6 | ||
| Business acquisitions & disposals | -$114.6 | $0.6 | ||
| Stock-based compensation | $11.5 | $11.8 | ||
| Total cash flows from operations | $132.8 | $98.8 | ||
| Investing activities | ||||
| Capital expenditures | -$38.5 | -$38 | ||
| Investments | ||||
| Total cash flows from investing | -$153.1 | -$37.4 | ||
| Financing activities | ||||
| Dividends paid | -$19.8 | -$20.4 | ||
| Sale and purchase of stock | -$46.6 | -$64 | ||
| Net borrowings | $70.1 | -$29.9 | ||
| Total cash flows from financing | $3.2 | -$114.6 | ||
| Effect of exchange rate | $2.1 | -$8 | ||
| Change in cash and equivalents | -$15 | -$61.2 | ||
Recent institutional transactions
| Quarter | Shareholder | Change |
Shares owned
Shares
|
Value (in thousands USD) |
|---|---|---|---|---|
| 2024 Q2 | Massmutual Trust Co Fsb/adv |
-88.59%
|
17 | $176 |
| 2024 Q1 | Ameriprise Financial Inc |
+200.60%
|
597,498 | $7,277,526 |
| 2024 Q1 | Bnp Paribas Financial Markets |
+222.59%
|
220,932 | $2,690,952 |
| 2024 Q1 | Bridge City Capital |
+88.85%
|
245,640 | $2,991,895 |
| 2024 Q1 | Comerica Bank |
-79.94%
|
15,238 | $185,599 |
| 2024 Q1 | Strs Ohio |
+481.43%
|
40,700 | $495 |
| 2024 Q1 | Legato Capital Management |
+51.57%
|
65,307 | $795,439 |
| 2024 Q1 | Bank Of New York Mellon Corp |
+4.70%
|
483,175 | $5,885,078 |
| 2024 Q1 | New York State Common Retirement Fund |
+37.78%
|
77,908 | $949 |
| 2024 Q1 | Quantbot Technologies L.P. |
+44.87%
|
53,341 | $649,693 |
Institutional shareholders
| Shareholder | Stake |
Shares owned
Shares
|
Value (in thousands USD) |
|---|---|---|---|
| Investment Counselors Of Maryland | 3.39% | 1,197,985 | |
| Geode Capital Management | 2.13% | 752,645 | |
| Ameriprise Financial Inc | 1.69% | 597,498 | |
| Bank Of New York Mellon Corp | 1.37% | 483,175 | |
| Bridge City Capital | 0.69% | 245,640 | |
| Bnp Paribas Financial Markets | 0.62% | 220,932 | |
| Loomis Sayles & Co L P | 0.50% | 177,565 | |
| Parametric Portfolio Associates | 0.46% | 162,090 | |
| Lsv Asset Management | 0.30% | 104,635 | |
| New York State Common Retirement Fund | 0.22% | 77,908 |
Sign up